Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Juan José
Lasarte Sagastibelza
Catedrático de Universidad
Juan José Lasarte Sagastibelza-rekin lankidetzan egindako argitalpenak (67)
2024
-
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model
Journal for immunotherapy of cancer, Vol. 12, Núm. 7
2023
-
Bases celulares de la respuesta inmunitaria
Biología celular biomédica (Elsevier), pp. 408-435
-
FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma
Molecular Therapy, Vol. 31, Núm. 1, pp. 48-65
-
Improvement of cognitive function in wild-type and Alzheimer´s disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells
Frontiers in Immunology, Vol. 14
-
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
Frontiers in Immunology, Vol. 14
-
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526
-
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer
EMBO Reports, Vol. 24, Núm. 8
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
-
The transcriptional regulator Sin3A balances IL-17A and Foxp3 expression in primary CD4 T cells
EMBO Reports, Vol. 24, Núm. 5
2022
-
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Science Advances, Vol. 8, Núm. 39
-
Electroporación irreversible: presente y futuro en el tratamiento del carcinoma hepatocelular
Anales del sistema sanitario de Navarra, Vol. 45, Núm. 3, pp. 81-90
-
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
Frontiers in Immunology, Vol. 13
-
Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma
Frontiers in Immunology, Vol. 13
-
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy
OncoImmunology, Vol. 11, Núm. 1
-
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 8
2021
-
Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
Frontiers in Immunology, Vol. 12
-
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11
-
Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma
BioMed Research International, Vol. 2021
-
Olfactory Characterization and Training in Older Adults: Protocol Study
Frontiers in Aging Neuroscience, Vol. 13
-
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
Emerging Microbes and Infections, Vol. 10, Núm. 1, pp. 1931-1946